Bringing the fundamentals into focus…
Back to BioNTech SE
How BioNTech SE stacks up
BNTX · against 100 other Healthcare companies of similar size
Profitability
24/ 100
Near the bottom of its peers.
Ranked #94 of 101 · scores higher than 7% of peers
Bars: peers in each 10-point band of the profitability score4 peers with a profitability score of 20–29, including BNTX · Click a bar to see the companies
Why profitability scores 24?
Weighted metrics compared with all Healthcare companies.Mainly because of its operating margin, return on invested capital and return on assets, which are weaker than most Healthcare peers.
- a thinner operating margin: weaker than 84% of peers. Operating margin: -49.0% vs peer median 7.1%
- a lower return on invested capital: weaker than 74% of peers. Return on invested capital: -9.6% vs peer median 4.7%
- a lower return on assets: weaker than 70% of peers. Return on assets: -5.2% vs peer median 1.7%
Metric by metric
Position: dot = BNTX, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | BNTX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 99 reported | -9.6% | 11.8% | 9% | 33% | |
| Operating marginHigher is better · 100 reported | -49.0% | 17.3% | 3% | 33% | |
| Return on assetsHigher is better · 97 reported | -5.2% | 6.3% | 11% | 33% | |
| Return on equityHigher is better · 94 reported | -9.3% | 11.8% | 8% | Context only | |
| Gross marginHigher is better · 103 reported | 76.6% | 61.2% | 82% | Context only |
Ranking by profitability score
Top 5 and the companies ranked around BNTX| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 17.9B USD | 99 | 76 | |
| 1 | 13.9B EUR (≈$15.3B) | 99 | 78 | |
| 1 | 20.0B AUD (≈$13.2B) | 99 | 77 | |
| 4 | 23.8B USD | 98 | 84 | |
| 5 | 193.6B HKD (≈$24.8B) | 97 | 78 | |
| 90 | 13.2B USD | 33 | 30 | |
| 91 | 21.7B USD | 31 | 32 | |
| 92 | 33.3B USD | 27 | 24 | |
| 93 | 14.0B USD | 25 | 31 | |
| 94 | 21.8B USD | 24 | 32 | |
| 95 | 13.7B USD | 22 | 45 | |
| 96 | 16.5B USD | 15 | 37 | |
| 97 | 23.5B USD | 14 | 27 | |
| 97 | 22.8B USD | 14 | 38 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score